-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-06-26
SKFOF:OTC- (USD)
COMMON STOCK | Specialty Chemicals |
Last Closing
USD 295.104Change
+11.94 (+4.22)%Market Cap
USD 49.08BVolume
46.00Verdict
Verdict
Values as of: 2024-06-26
COMMON STOCK | Specialty Chemicals |
Last Closing
USD 295.104Change
+11.94 (+4.22)%Market Cap
USD 49.08BVolume
46.00Verdict
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
AIQUY | Air Liquide SA ADR |
N/A |
USD 111.54B |
AIQUF | L'Air Liquide S.A |
N/A |
USD 103.93B |
PTCAY | Chandra Asri Petrochemical Tbk.. |
N/A |
USD 51.18B |
SXYAY | Sika AG ADR |
-0.40 (-1.38%) |
USD 45.88B |
GVDNY | Givaudan SA ADR |
-2.28 (-2.35%) |
USD 44.78B |
GVDBF | Givaudan SA |
N/A |
USD 42.62B |
NVZMF | Novozymes A/S B |
N/A |
USD 28.88B |
NVZMY | Novozymes AS |
-0.78 (-1.26%) |
USD 27.24B |
EMSHF | EMS-CHEMIE HOLDING AG |
N/A |
USD 19.37B |
SYIEY | Symrise Ag PK |
-0.22 (-0.72%) |
USD 16.87B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
EXV8:XETRA | iShares STOXX Europe 600 .. | 10.06 % | 0.00 % |
-0.32 (0.00%) |
USD 0.11B |
DXSC:XETRA | Xtrackers - Stoxx Europe .. | 8.83 % | 0.00 % |
-1.20 (0.00%) |
USD 0.05B |
STP:PA | SSgA SPDR ETFs Europe II .. | 5.87 % | 0.00 % |
-1.95 (0.00%) |
USD 0.41B |
SPYP:F | SSgA SPDR ETFs Europe II .. | 5.87 % | 0.00 % |
-2.70 (0.00%) |
USD 0.41B |
SPYP:XETRA | SPDR® MSCI Europe Materi.. | 5.87 % | 0.00 % |
-1.85 (0.00%) |
USD 0.38B |
STPX:SW | SPDR® MSCI Europe Materi.. | 5.87 % | 0.00 % |
+0.10 (+0.00%) |
USD 0.41B |
CHSRII:SW | UBS(Lux)Fund Solutions .. | 5.58 % | 0.00 % |
-0.02 (0.00%) |
USD 0.30M |
CHSRI:SW | UBS ETF (CH) - MSCI Switz.. | 4.99 % | 0.00 % |
-0.10 (0.00%) |
USD 368,190.74B |
CHSRIA:SW | UBS ETF (CH) MSCI Switzer.. | 4.99 % | 0.00 % |
-0.04 (0.00%) |
USD 492,935.36B |
CHSR:XETRA | UBS(Lux)Fund Solutions .. | 4.98 % | 0.00 % |
-0.06 (0.00%) |
USD 0.17B |
TINT | ProShares Smart Materials.. | 4.60 % | 0.00 % |
+0.03 (+0.00%) |
USD 1.68M |
DXS0:XETRA | Xtrackers SLI UCITS ETF 1.. | 4.55 % | 0.00 % |
-0.90 (0.00%) |
USD 0.26B |
XSLI:SW | Xtrackers SLI UCITS ETF 1.. | 4.55 % | 0.00 % |
-0.10 (0.00%) |
USD 0.28B |
SLICHA:SW | UBS ETF (CH) – SLI® (C.. | 4.53 % | 0.00 % |
-0.60 (0.00%) |
USD 32,912.73B |
EXI1:XETRA | iShares SLI UCITS ETF (DE.. | 4.51 % | 0.00 % |
-0.66 (0.00%) |
USD 0.37B |
SMIEX:SW | iShares SLI UCITS ETF (DE.. | 4.51 % | 0.00 % |
-0.20 (0.00%) |
USD 5,933.96B |
CSSLI:SW | iShares SLI® ETF (CH) | 4.50 % | 0.00 % |
-0.55 (0.00%) |
USD 0.58B |
C030:XETRA | Amundi Index Solutions - .. | 3.97 % | 0.00 % |
-1.16 (0.00%) |
USD 0.13B |
CBCH30:SW | 3.90 % | 0.00 % |
N/A |
N/A | |
SMICHA:SW | UBS ETF (CH) – SMI® (C.. | 3.52 % | 0.00 % |
-0.18 (0.00%) |
USD 17,142.72B |
CSSMI:SW | iShares SMI® ETF (CH) | 3.47 % | 0.00 % |
-0.24 (0.00%) |
USD 2.06B |
XSMC:SW | Xtrackers Switzerland UCI.. | 3.35 % | 0.00 % |
-0.10 (0.00%) |
USD 0.46B |
XSMI:SW | Xtrackers Switzerland UCI.. | 3.35 % | 0.00 % |
-0.70 (0.00%) |
USD 1.24B |
DBXS:XETRA | Xtrackers - Switzerland U.. | 3.12 % | 0.00 % |
-0.36 (0.00%) |
USD 1.34B |
SWUSAH:SW | UBS ETF (CH) – MSCI Swi.. | 2.90 % | 0.00 % |
+0.05 (+0.00%) |
USD 226,274.21B |
SWEUAH:SW | UBS ETF (CH) – MSCI Swi.. | 2.88 % | 0.00 % |
N/A |
USD 226,274.20B |
SWICHA:SW | UBS ETF (CH) – MSCI Swi.. | 2.86 % | 0.00 % |
-0.03 (0.00%) |
USD 226,274.25B |
SW2CHA:SW | UBS(Lux)Fund Solutions .. | 2.85 % | 0.00 % |
-0.06 (0.00%) |
USD 0.45B |
SW2CHB:SW | UBS(Lux)Fund Solutions .. | 2.85 % | 0.00 % |
-0.03 (0.00%) |
USD 1.51B |
SW2UKD:SW | UBS(Lux)Fund Solutions .. | 2.85 % | 0.00 % |
N/A |
USD 0.03B |
CHEUR:SW | UBS(Lux)Fund Solutions .. | 2.85 % | 0.00 % |
N/A |
USD 0.18B |
CHEURD:SW | UBS(Lux)Fund Solutions .. | 2.85 % | 0.00 % |
N/A |
USD 4.24M |
CHUSD:SW | UBS(Lux)Fund Solutions .. | 2.85 % | 0.00 % |
-0.03 (0.00%) |
USD 0.07B |
CHUSDD:SW | UBS(Lux)Fund Solutions .. | 2.85 % | 0.00 % |
N/A |
USD 0.01B |
S2HGBD:SW | UBS(Lux)Fund Solutions .. | 2.85 % | 0.00 % |
N/A |
USD 0.06B |
S2HGBA:SW | UBS(Lux)Fund Solutions .. | 2.85 % | 0.00 % |
N/A |
USD 8.26M |
SPICHA:SW | UBS ETF (CH) – SPI® (C.. | 2.75 % | 0.00 % |
-0.28 (0.00%) |
USD 131,872.43B |
CHSPI:SW | iShares Core SPI® ETF (C.. | 2.61 % | 0.00 % |
-0.18 (0.00%) |
USD 3.23B |
SPF1:F | SSgA SPDR ETFs Europe II .. | 1.08 % | 0.00 % |
N/A |
N/A |
ZPRC:F | SSgA SPDR ETFs Europe II .. | 1.08 % | 0.00 % |
+0.05 (+0.00%) |
USD 0.61B |
SPF1:XETRA | SPDR Refinitiv Global Con.. | 1.08 % | 0.00 % |
+0.07 (+0.00%) |
USD 0.33B |
ZPRC:XETRA | SPDR Thomson Reuters Glob.. | 1.08 % | 0.00 % |
+0.04 (+0.00%) |
USD 0.53B |
GCVB:SW | SPDR Refinitiv Global Con.. | 1.08 % | 0.00 % |
+0.33 (+0.00%) |
USD 0.71B |
GCVC:SW | SPDR Refinitiv Global Con.. | 1.08 % | 0.00 % |
+0.16 (+0.00%) |
USD 0.11B |
GLCB:LSE | SPDR Thomson Reuters Glob.. | 1.07 % | 0.00 % |
+0.02 (+0.00%) |
USD 0.71B |
EWL | iShares MSCI Switzerland .. | 0.00 % | 0.47 % |
-0.11 (0.00%) |
USD 1.16B |
PIZ | Invesco DWA Developed Mar.. | 0.00 % | 0.80 % |
+0.10 (+0.00%) |
USD 0.14B |
FLSW | Franklin FTSE Switzerland.. | 0.00 % | 0.09 % |
-0.08 (0.00%) |
USD 0.06B |
MTRL:LSE | SPDR® MSCI Europe Materi.. | 0.00 % | 0.00 % |
-1.70 (0.00%) |
USD 0.41B |
XSPR:LSE | Xtrackers MSCI Europe Mat.. | 0.00 % | 0.00 % |
-85.00 (0.00%) |
USD 0.04B |
UC93:LSE | UBS MSCI Switzerland 20/3.. | 0.00 % | 0.00 % |
-5.00 (0.00%) |
USD 8.26M |
UC94:LSE | UBS(Lux)Fund Solutions .. | 0.00 % | 0.00 % |
-4.25 (0.00%) |
USD 0.06B |
C030:F | Lyxor DJ Switzerland Tita.. | 0.00 % | 0.00 % |
-1.14 (0.00%) |
USD 0.01B |
DBXS:F | Xtrackers - Switzerland U.. | 0.00 % | 0.00 % |
N/A |
USD 1.23B |
DXS0:F | Xtrackers - SLI UCITS ETF | 0.00 % | 0.00 % |
-1.55 (0.00%) |
USD 0.28B |
DXSC:F | Xtrackers Stoxx Europe 60.. | 0.00 % | 0.00 % |
N/A |
USD 0.04B |
EXI1:F | iShares SLI UCITS ETF (DE.. | 0.00 % | 0.00 % |
-0.94 (0.00%) |
USD 0.37B |
EXV8:F | iShares STOXX Europe 600 .. | 0.00 % | 0.00 % |
-0.39 (0.00%) |
USD 0.07B |
1391:TSE | 0.00 % | 0.00 % |
N/A |
N/A | |
FGGE:CA | Franklin Global Growth Fu.. | 0.00 % | 0.00 % |
-0.02 (0.00%) |
CAD 0.01B |
Market Performance vs. Industry/Classification (Specialty Chemicals) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -8.07% | 45% | F | 42% | F | ||
Dividend Return | 1.10% | 27% | F | 20% | F | ||
Total Return | -6.97% | 41% | F | 41% | F | ||
Trailing 12 Months | |||||||
Capital Gain | 4.90% | 62% | D | 64% | D | ||
Dividend Return | 1.25% | 26% | F | 16% | F | ||
Total Return | 6.16% | 63% | D | 63% | D | ||
Trailing 5 Years | |||||||
Capital Gain | 75.40% | 91% | A- | 85% | B | ||
Dividend Return | 7.67% | 33% | F | 26% | F | ||
Total Return | 83.07% | 90% | A- | 85% | B | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 19.93% | 69% | C- | 66% | D+ | ||
Dividend Return | 20.87% | 64% | D | 63% | D | ||
Total Return | 0.94% | 15% | F | 21% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 35.58% | 60% | D- | 64% | D | ||
Risk Adjusted Return | 58.65% | 91% | A- | 91% | A- | ||
Market Capitalization | 49.08B | 98% | N/A | 98% | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median dividend growth in the previous 5 years compared to its sector.